MARKET

CODX

CODX

Co-Diagnostics Inc
NASDAQ
1.125
+0.015
+1.35%
Opening 12:46 03/28 EDT
OPEN
1.090
PREV CLOSE
1.110
HIGH
1.144
LOW
1.080
VOLUME
20.06K
TURNOVER
0
52 WEEK HIGH
1.890
52 WEEK LOW
0.9750
MARKET CAP
35.17M
P/E (TTM)
-0.9344
1D
5D
1M
3M
1Y
5Y
Weekly Report: what happened at CODX last week (0318-0322)?
Weekly Report · 3d ago
Weekly Report: what happened at CODX last week (0311-0315)?
Weekly Report · 03/18 12:05
Co-Diagnostics Inc Welcomes Richard Abbott as New President
TipRanks · 03/15 20:24
Co-Diagnostics Is Maintained at Neutral by HC Wainwright & Co.
Dow Jones · 03/15 10:57
Co-Diagnostics Price Target Cut to $2.50/Share From $3.00 by HC Wainwright & Co.
Dow Jones · 03/15 10:57
HC Wainwright & Co. Maintains Neutral on Co-Diagnostics, Lowers Price Target to $2.5
Benzinga · 03/15 10:49
Maintaining Hold on Co-Diagnostics Amid Revenue Decline and Potential EUA Boost
TipRanks · 03/15 10:27
CODX Stock Earnings: Co-Diagnostics Misses EPS, Misses Revenue for Q4 2023
Co-Diagnostics reported earnings per share of -50 cents for the fourth quarter of 2023. This was below the analyst estimate of -20 cents. The company reported revenue of $3.56 million, 1.80% lower than the estimate for the same period.
Investorplace · 03/15 00:55
More
About CODX
Co-Diagnostics, Inc. is a molecular diagnostics company, which develops, manufactures and markets diagnostics technologies. The Company’s technologies are utilized for tests that are designed using the detection and/or analysis of nucleic acid molecules (DNA or RNA). The Company also uses its proprietary technology to design specific tests for its Co-Dx PCR platform and to locate genetic markers for use in applications other than infectious disease. Its diagnostics systems enable dependable, low-cost, molecular testing for organisms and genetic diseases by automating or simplifying historically complex procedures in both the development and administration of tests. It is developing a portable diagnostic device and test system designed for point-of-care and at-home use. The system consists of its PCR instrument that it refers to as the Co-Dx PCR Pro instrument, its proprietary diagnostic test cup system and a mobile application to be installed on the user’s mobile device.

Webull offers Co-Diagnostics Inc stock information, including NASDAQ: CODX real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, CODX stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading CODX stock methods without spending real money on the virtual paper trading platform.